Select Publications
Journal articles
2024, 'Next-Generation Sequencing Methods for Near-Real-Time Molecular Epidemiology of HIV and HCV', Reviews in Medical Virology, 34, http://dx.doi.org/10.1002/rmv.70001
,2024, 'Systematic Review of the Efficacy and Safety of RSV-Specific Monoclonal Antibodies and Antivirals in Development', Reviews in Medical Virology, 34, http://dx.doi.org/10.1002/rmv.2576
,2024, 'The resurgence of influenza A/H3N2 virus in Australia after the relaxation of COVID-19 restrictions during the 2022 season', Journal of Medical Virology, 96, http://dx.doi.org/10.1002/jmv.29922
,2024, 'Acute Q fever in patients with an influenza-like illness in regional New South Wales, Australia', PLoS Neglected Tropical Diseases, 18, http://dx.doi.org/10.1371/journal.pntd.0012385
,2024, 'Contextualising COVID-19 in 2024', Microbiology Australia, 45, pp. 3, http://dx.doi.org/10.1071/MA24002
,2024, 'Clinical, Genomic, and Immunological Characterization of RSV Surge in Sydney, Australia, 2022', Pediatrics, 153, http://dx.doi.org/10.1542/peds.2023-063667
,2024, 'Genome characterization of influenza A and B viruses in New South Wales, Australia, in 2019: A retrospective study using high-throughput whole genome sequencing', Influenza and other Respiratory Viruses, 18, http://dx.doi.org/10.1111/irv.13252
,2023, 'Broadly neutralizing SARS-CoV-2 antibodies through epitope-based selection from convalescent patients', Nature Communications, 14, http://dx.doi.org/10.1038/s41467-023-36295-5
,2023, 'Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2', Antiviral Research, 217, http://dx.doi.org/10.1016/j.antiviral.2023.105677
,2023, 'Erratum: Machine Learning Color Feature Analysis of a High Throughput Nanoparticle Conjugate Sensing Assay (Analytical Chemistry (2023) 95:6 (550-6558) DOI: 10.1021/acs.analchem.2c05292)', Analytical Chemistry, 95, pp. 8393, http://dx.doi.org/10.1021/acs.analchem.3c01892
,2023, 'Machine Learning Color Feature Analysis of a High Throughput Nanoparticle Conjugate Sensing Assay', Analytical Chemistry, 95, pp. 6550 - 6558, http://dx.doi.org/10.1021/acs.analchem.2c05292
,2023, 'Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level', eBioMedicine, 90, http://dx.doi.org/10.1016/j.ebiom.2023.104545
,2023, 'Persistence of a Frameshifting Deletion in SARS-CoV-2 ORF7a for the Duration of a Major Outbreak', Viruses, 15, http://dx.doi.org/10.3390/v15020522
,2022, 'Simultaneous monitoring of eight human respiratory viruses including SARS-CoV-2 using liquid chromatography-tandem mass spectrometry', Scientific Reports, 12, http://dx.doi.org/10.1038/s41598-022-16250-y
,2022, 'SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern', eBioMedicine, 84, http://dx.doi.org/10.1016/j.ebiom.2022.104270
,2022, 'Persistent high-level shedding of cultivable SARS-CoV-2 Delta virus 33 days after onset of COVID-19 in a hospitalized patient with pneumonia', Journal of Medical Virology, 94, pp. 4043 - 4046, http://dx.doi.org/10.1002/jmv.27832
,2022, 'Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia', Nature Microbiology, 7, pp. 896 - 908, http://dx.doi.org/10.1038/s41564-022-01135-7
,2022, 'Transplacental transfer of RSV antibody in Australian First Nations infants', Journal of Medical Virology, 94, pp. 782 - 786, http://dx.doi.org/10.1002/jmv.27383
,2022, 'Viruses associated with acute respiratory infection in a community-based cohort of healthy New Zealand children', Journal of Medical Virology, 94, pp. 454 - 460, http://dx.doi.org/10.1002/jmv.25493
,2021, 'Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability', Immunity, 54, pp. 2908 - 2921.e6, http://dx.doi.org/10.1016/j.immuni.2021.10.019
,2021, 'Serological Detection of SARS-CoV-2 IgG Using Commercially Available Enzyme Immunoassays on Dried Blood Spots Collected from Patients', Microbiology Spectrum, 9, http://dx.doi.org/10.1128/Spectrum.01245-21
,2021, 'SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants', PLoS Medicine, 18, http://dx.doi.org/10.1371/journal.pmed.1003656
,2021, 'Sars coronavirus-2 microneutralisation and commercial serological assays correlated closely for some but not all enzyme immunoassays', Viruses, 13, http://dx.doi.org/10.3390/v13020247
,2021, 'Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies', mAbs, 13, http://dx.doi.org/10.1080/19420862.2021.1922134
,2020, 'SARS-CoV-2 neutralizing antibodies; longevity, breadth, and evasion by emerging viral variants', , http://dx.doi.org/10.1101/2020.12.19.20248567
,2020, 'SARS-CoV-2 in human milk is inactivated by Holder pasteurisation but not cold storage', Journal of Paediatrics and Child Health, 56, pp. 1872 - 1874, http://dx.doi.org/10.1111/jpc.15065
,2020, 'Virus isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for diagnostic and research purposes', Pathology, 52, pp. 760 - 763, http://dx.doi.org/10.1016/j.pathol.2020.09.012
,2020, 'Evaluation of commercially available viral transport medium (VTM) for SARS-CoV-2 inactivation and use in point-of-care (POC) testing', Viruses, 12, pp. 1208, http://dx.doi.org/10.3390/v12111208
,2020, 'Serological testing for infectious diseases markers of donor specimens from 24 h after death show no significant change in outcomes from other specimens', Cell and Tissue Banking, 21, pp. 171 - 179, http://dx.doi.org/10.1007/s10561-020-09810-x
,2020, 'Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies', , http://dx.doi.org/10.1101/2020.12.14.422791
,2020, 'SARS Coronavirus-2 microneutralisation and commercial serological assays correlated closely for some but not all enzyme immunoassays', , http://dx.doi.org/10.1101/2020.12.07.20245696
,2020, 'SARS-CoV-2 in human milk is inactivated by Holder pasteurization but not cold storage', , http://dx.doi.org/10.1101/2020.06.18.20134395
,2018, 'Proficiency testing for the detection of Middle East respiratory syndrome coronavirus demonstrates global capacity to detect Middle East respiratory syndrome coronavirus', Journal of Medical Virology, 90, pp. 1827 - 1833, http://dx.doi.org/10.1002/jmv.25266
,2018, 'Systematic review of the impact of point-of-care testing for influenza on the outcomes of patients with acute respiratory tract infection', Reviews in Medical Virology, 28, pp. e1995, http://dx.doi.org/10.1002/rmv.1995
,